BS drug pair is effective for depression and tumor treatment, but simultaneous targeting mechanism remains unclear. Understanding could lead to new treatment approaches for both conditions.
Researchers synthesized gold nanoparticles using plant leaf extracts as reducing and capping agents to create safer, targeted therapies for oral cancer. This could offer a promising, less toxic treatment option for tongue squamous cell carcinoma with poor prognosis, particularly in developing nations.
Atractylenolide II (AT-II) inhibits endometrial cancer cell growth and glycolysis, induces apoptosis by blocking PADI3-ERK pathway. AT-II may be a potential novel therapy for endometrial cancer.
TL;DR: Curcumin from turmeric has anti-inflammatory, antioxidant, and potential anticancer effects by interacting with key proteins. Promising for cancer and inflammatory diseases, with growing therapeutic applications.
Researchers found that combining magnolol and betulinic acid oil improved their anti-tumor effects, but their low solubility and stability hindered oral bioavailability. This could lead to new methods for cancer treatment.
Green synthesis of silver nanoparticles using leaf extract showed promise in nanotechnology for biomedical applications. The nanoparticles were effective against cancer cells by inducing cytotoxicity, DNA damage, and altering antioxidant enzymes, suggesting potential for cancer therapy.
Study evaluates effectiveness and safety of Compound Kushen Injection (CKI) combined with chemotherapy for treating advanced colorectal cancer. Shows promise in comprehensive treatment of CRC.
Researchers used network pharmacology to study the Banxia-Shengjiang drug pair's effect on gastric cancer. They identified key target genes like PTGS2 and MMP9, which could be important for inhibiting GC through immune modulation. This study provides insights for potential therapeutic strategies in GC treatment.